SONN hits 52-week low, trading at 0.82 USD By Investing.com
Sonnet BioTherapeutics Holdings (NASDAQ:), Inc. stock recently hit a 52-week low, trading at $0.82. This represents a significant decline for the biopharmaceutical company that specializes in developing innovative targeted biologic…
